Caixin
Caixin Global – Latest China News & Headlines

Home >

TRENDING
Zhongji Innolight Slides in Hong Kong Debut Following $7 Billion IPO
DeepSeek Releases Official V4-Flash Model as China’s AI Race Intensifies
ByteDance, MiniMax Roll Out Upgraded AI-Video Models
LATEST
DeepSeek Releases Official V4-Flash Model as China’s AI Race Intensifies
ByteDance, MiniMax Roll Out Upgraded AI-Video Models
Zhongji Innolight Slides in Hong Kong Debut Following $7 Billion IPO
Zhongji Innolight Rebounds After Buyback Plan, Easing Jitters Ahead of Hong Kong Debut
Lenovo Capital Executive Warns of Reckoning for China’s Crowded AI-Powered Robotics Sector
U.S. Takes Aim at Chinese Robot-Makers With Sweeping Import Ban
SK Hynix’s Earnings Miss Adds to Anxiety Over AI Boom
Consumer-Electronics Makers Bet on AI Agents as Phones, Glasses Compete
Moonshot Open-Sources Kimi K3 as U.S.-China AI Tensions Intensify
TikTok Faces New EU Penalty Threat Over Children’s Safety
AgiBot Begins Hong Kong IPO Process as China’s Embodied-AI Startups Race to List
Tencent Folds Multimodal, LLM Teams Into New AI Unit
Kai-Fu Lee Says AI Will Soon Reshape Corporate Reporting and Management
Flashy Robot Demos at WAIC Mask Struggles With Real-World Deployment
Kimi K3 Demand Surge Forces Moonshot AI to Pause Sign-Ups
Chinese AI Chip Startups Look Beyond the Cloud to Edge Devices
Biren Unveils 1,024-GPU Optical Super Node Architecture
As AI Agents Take Off, Integration Becomes an Obstacle
Zhongji Innolight Clears Hong Kong Listing Hearing for Potential $7 Billion IPO
China Issues First Level 3 Certifications Under AI Device Grading System

By Han Wei / Dec 29, 2018 02:40 AM / Business & Tech

Photo: VCG

Photo: VCG

An initial investigation of herbal medicines and health foods producer Quanjian Group Co. Ltd. found that the company committed violations by exaggerating the benefits of its products, the state broadcaster China Central Television reported Friday.

A formal investigation has been initiated against Quanjian by the Tianjin city market regulator on allegations of violating market competition law, said the report.

Tianjin-based Quanjian has been under public scrutiny since Dingxiangyuan, an online health news portal, published an article Tuesday reporting that the company exaggerated the benefits of its products, which contributed to the 2015 death of a 4-year-old with cancer. Tianjin authorities sent inspectors to the company after the report went viral.

Quanjian also faces questions on whether it was involved in pyramid sales, which are banned in China. An official on the inspection team said the probe is still underway, according to the CCTV report.

Related: ‘Miracle’ Herbal Cures Accused of Contributing to Child's Death

Share this article
Open WeChat and scan the QR code